Integrated Production-Distribution Problem Sample Clauses

Integrated Production-Distribution Problem. ‌ In the last couple of decades there has been an increased focus on optimizing and stream- lining the supply chain in order to reduce costs. The advance in technology along with new models and algorithms have given better information and communication systems that has made coordination of the whole supply chain more manageable. Larger parts of the supply chain is now optimized globally in one step. In the case of the IPDP this means that both the manufacturing, inventory at the plant, the transportation and the inventory monitoring at the retailers are considered at the same time. This is in contrast to the more traditional decoupled two-step approach, where the production plan is produced first, and then a dis- tribution plan is made based on the production plan. In most cases such global integrated optimizing of the supply chain gives cost reductions far beyond traditional optimization approaches. As briefly mentioned, the Integrated Production-Distribution Problem considers both the manufacturing of products at the plant, the distribution to the retailers and managing their inventory levels. The IPDP can therefore be broken down to 1) Capacitated Lot Sizing Problem (CLSP) with multiple products and periods, and 2) a multi period split delivery CVRP. Each of these two sub-problems are considered to be computational hard to solve, since both problems belong to the complexity class NP-Hard. In the last couple of years there has been published some interesting articles regarding solving the IPDP. Xxxxxx et al. (2007) developed a reactive GRASP method for a combined production-distribution problem where the goal is to minimize the sum of three costs, namely: production, transportation and inventory costs. Later X. Xxxxxx, X. Xxxxx (2009) developed and applied a Memetic Algorithm with Population Management (MA|PM) to the exact same test-instances. These instances concern a single product and 50, 100 and 200 customers in a horizon of 20 time-periods. The results show a saving of 23 % or more, over classical decoupled optimization methods. Archetti et al. (2007) had another approach, they used an exact method, branch and cut, for solving the problem to optimality while following and comparing three vendor inventory management strategies. The first strategy is the order-up-to-level (VMIR-OU), the second strategy allows for any delivery quantity as long as it is not violating the minimum or maximum inventory levels at the vendor (VMIR-ML). The third strategy is ...
AutoNDA by SimpleDocs

Related to Integrated Production-Distribution Problem

  • Interconnection Product Options Interconnection Customer has selected the following (checked) type of Interconnection Service:

  • Program Components Activities and services delivered under this Program Element align with Foundational Programs and Foundational Capabilities, as defined in Oregon’s Public Health Modernization Manual, (xxxx://xxx.xxxxxx.xxx/oha/PH/ABOUT/TASKFORCE/Documents/public_health_modernization_man ual.pdf) as well as with public health accountability outcome and process metrics (if applicable) as follows:

  • Distribution Protocol (1) At a time wholly within the discretion of Class Counsel, but on notice to the Settling Defendants, Class Counsel will bring motions seeking orders from the Courts approving the Distribution Protocol. The motions can be brought before the Effective Date, but the orders approving the Distribution Protocol shall be conditional on the Effective Date occurring.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • SOURCE CODE ESCROW FOR LICENSED PRODUCT If Source Code or Source Code escrow is offered by either Contractor or Product manufacturer or developer to any other commercial customers, Contractor shall either: (i) provide Licensee with the Source Code for the Product; or (ii) place the Source Code in a third party escrow arrangement with a designated escrow agent who shall be named and identified to the State, and who shall be directed to release the deposited Source Code in accordance with a standard escrow agreement acceptable to the State; or (iii) will certify to the State that the Product manufacturer/developer has named the State, acting by and through the Authorized User, and the Licensee, as a named beneficiary of an established escrow arrangement with its designated escrow agent who shall be named and identified to the State and Licensee, and who shall be directed to release the deposited Source Code in accordance with the terms of escrow. Source Code, as well as any corrections or enhancements to such source code, shall be updated for each new release of the Product in the same manner as provided above and such updating of escrow shall be certified to the State in writing. Contractor shall identify the escrow agent upon commencement of the Contract term and shall certify annually that the escrow remains in effect in compliance with the terms of this clause. The State may release the Source Code to Licensees under this Contract who have licensed Product or obtained services, who may use such copy of the Source Code to maintain the Product.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Test Samples The Contractor is responsible for providing Samples of sufficient size for test purposes and for coordinating such tests with the Work Progress Schedule to avoid delay.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!